Sponsor pipeline

Noorik Biopharmaceuticals AG clinical trial pipeline

Get alerts when Noorik Biopharmaceuticals AG's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06256432 Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Hepatorenal Syndrome Active, Not Recruiting 2026-04-13
Get alerts when Noorik Biopharmaceuticals AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free